EyePoint Pharmaceuticals (EYPT) Revenue (2010 - 2026)
EyePoint Pharmaceuticals (EYPT) revenue from Sep 30, 2010 to Mar 31, 2026. The TTM EyePoint Pharmaceuticals (EYPT) revenue is $7.62M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
Quarterly Revenue
EyePoint Pharmaceuticals (EYPT) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -86.40% |
| 3 Years TTM | -42.36% |
| 5 Years TTM | -25.97% |
| 10 Years TTM | +15.98% |
| All Time TTM | +1.49% |
Annual Revenue change of EyePoint Pharmaceuticals (EYPT)
| Year | Revenue | Change |
|---|---|---|
| 2026 | $700K | -97.77% |
| 2025 | $31M | -27.50% |
| 2024 | $43M | -5.98% |
| 2023 | $46M | +11.16% |
| 2022 | $41M | +12.07% |
| 2021 | $37M | +7.26% |
| 2020 | $34M | +69.16% |
| 2019 | $20M | +345.51% |
| 2018 | $4.57M | +391.40% |
| 2017 | $930K | +232.14% |
| 2016 | $280K | -47.17% |
| 2015 | $530K | +1.92% |
| 2014 | $520K | -11.86% |
| 2013 | $590K | N/A |
| 2012 | $590K | -6.35% |
| 2011 | $630K | +53.66% |
| 2010 | $410K | N/A |
Comparison EyePoint Pharmaceuticals (EYPT) five years revenue CAGR with competitors
EyePoint Pharmaceuticals (EYPT) five years revenue CAGR is -25.98%.